CD9, a novel potential biomarker of sarcopenia
Abstract Sarcopenia is defined as a progressive decrease in skeletal muscle mass and strength due to ageing, and is associated with adverse outcomes such as falls, fractures, and physical disability, leading to increased healthcare expenditures and mortality risks. Although sarcopenia has recently b...
Saved in:
| Main Authors: | Lin Yin, Na Li, Peirong Bai, Shasha Wu, Xuena Wang, Bin Lu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-04331-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sphingolipid metabolites as potential circulating biomarkers for sarcopenia in men
by: Je Hyun Seo, et al.
Published: (2024-12-01) -
Carnitine Metabolite as a Potential Circulating Biomarker for Sarcopenia in Men
by: Je Hyun Seo, et al.
Published: (2025-02-01) -
HOXA9 and CD163 potentiate pancreatic ductal adenocarcinoma progression
by: Aiat Shaban Hemida, et al.
Published: (2024-10-01) -
Circulatory titin and miR-451a are possible sarcopenia biomarkers in elderly people
by: Roberta Mancuso, et al.
Published: (2025-06-01) -
CHST3, PGBD5, and SLIT2 can be identified as potential genes for the diagnosis and treatment of osteoporosis and sarcopenia
by: Xingyao Yang, et al.
Published: (2025-01-01)